Skip to content

Clinical trials

Phase 3 Anemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 3 Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20071
20092
20152
20191
20214
20233
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting5
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Hoffmann-La Roche2
Kind Pharmaceuticals LLC2
Kyntra Bio2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Shenzhen Salubris Pharmaceuticals Co., Ltd.2
Amgen1
Bristol-Myers Squibb1
Celgene1
Centers for Disease Control and Prevention1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia19
Hemoglobinuria, Paroxysmal2
Myelodysplastic Syndromes2
Renal Insufficiency2
Renal Insufficiency, Chronic2
Anemia, Diamond-Blackfan1
Birth Weight1
Bronchopulmonary Dysplasia1
Carcinoma, Non-Small-Cell Lung1
Lung Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.